Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cells

Tumor Biology

Volumn 37, Issue 3, 2016, Pages 3549-3560

  Bi, Yunke ^a,b   Shen, Chen ^a,b   Li, Chenguang ^c   Liu, Yaohua ^a,b   Gao, Dandan ^d   Shi, Chen ^e   Peng, Fei ^a,b   Liu, Zhendong ^a,b   Zhao, Boxian ^a,b   Zheng, Zhixing ^a,b   Wang, Xiaoxiong ^a,b   Hou, Xu ^a,b   Liu, Huailei ^a,b   Wu, Jianing ^a,b   Zou, Huichao ^b   Wang, Kaikai ^a,b   Zhong, Chen ^a,b   Zhang, Jiakang ^a,b   Shi, Changbin ^f   Zhao, Shiguang ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Department of Endocrinology   (China)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Autophagy; Glioma; Quercetin

Indexed keywords

3 METHYLADENINE; BECLIN 1; CASPASE 3; CHLOROQUINE; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1A 1B LIGHT CHAIN 3; QUERCETIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; 3-METHYLADENINE; ADENINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL VACUOLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FLOW CYTOMETRY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME; WEIGHT CHANGE; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN NEOPLASMS; CANCER STAGING; CELL PROLIFERATION; DRUG EFFECTS; MORTALITY; PATHOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ADENINE; ANIMALS; AUTOPHAGY; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHLOROQUINE; GLIOMA; HUMANS; MALE; NEOPLASM STAGING; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84964475923     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4125-4     Document Type: Article

References (42)

1. Frassanito P, Tamburrini G, Massimi L, Caldarelli M, Di Rocco C. Ghost tumors of the central nervous system: definition, clinical implications, and proposal of classification. World Neurosurg. 2015;84(3):663–70.
2. Meyer MA. Malignant gliomas in adults. N Engl J Med. 2008;359(17):1850.
3. Zhu Z, Khan MA, Weiler M, Blaes J, Jestaedt L, Geibert M, et al. Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. Cell Stem Cell. 2014;15(2):185–98.
4. Grossman SA, Batara JF. Current management of glioblastoma multiforme. Semin Oncol. 2004;31(5):635–44.
5. Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, et al. A high Notch pathway activation predicts response to gamma secretase inhibitors in proneural subtype of glioma tumor-initiating cells. Stem Cells. 2014;32(1):301–12.
6. Watkins S, Robel S, Kimbrough IF, Robert SM, Ellis-Davies G, Sontheimer H. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun. 2014;5:4196.
7. Kim H, Moon JY, Ahn KS, Cho SK. Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells. Oxid Med Cell Longev. 2013;2013:596496.
8. Jakubowicz-Gil J, Langner E, Badziul D, Wertel I, Rzeski W. Apoptosis induction in human glioblastoma multiforme T98G cells upon temozolomide and quercetin treatment. Tumour Biol. 2013;34(4):2367–78.
9. Kim EJ, Choi CH, Park JY, Kang SK, Kim YK. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem Res. 2008;33(6):971–9.
10. Siegelin MD, Reuss DE, Habel A, Rami A, von Deimling A. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. Neuro Oncol. 2009;11(2):122–31.
11. Wang G, Wang JJ, Chen XL, Du SM, Li DS, Pei ZJ, et al. The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death. Cell Death Dis. 2013;4, e746.
12. Faria A, Meireles M, Fernandes I, Santos-Buelga C, Gonzalez-Manzano S, Duenas M, et al. Flavonoid metabolites transport across a human BBB model. Food Chem. 2014;149:190–6.
13. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med. 2004;36(5):592–604.
14. Yang Y, Bai L, Li X, Xiong J, Xu P, Guo C, et al. Transport of active flavonoids, based on cytotoxicity and lipophilicity: an evaluation using the blood-brain barrier cell and Caco-2 cell models. Toxicol In Vitro. 2014;28(3):388–96.
15. Mrozikiewicz PM, Bogacz A, Bartkowiak-Wieczorek J, Kujawski R, Mikolajczak PL, Ozarowski M, et al. Screening for impact of popular herbs improving mental abilities on the transcriptional level of brain transporters. Acta Pharm. 2014;64(2):223–32.
16. Tanida I. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal. 2011;14(11):2201–14.
17. Fantin VR, Abraham RT. Self-eating limits EGFR-dependent tumor growth. Cell. 2013;154(6):1184–6.
18. Wrighton KH. Autophagy: selecting ER for eating. Nat Rev Mol Cell Biol. 2015;16(7):389.
19. Mochida K, Oikawa Y, Kimura Y, Kirisako H, Hirano H, Ohsumi Y, et al. Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus. Nature. 2015;522(7556):359–62.
20. Su Z, Yang Z, Xu Y, Chen Y, Yu Q. MicroRNAs in apoptosis, autophagy and necroptosis. Oncotargrt. 2015;6(11):8474–90.
21. Cecconi F, Jaattela M. Targeting ions-induced autophagy in cancer. Cancer Cell. 2014;26(5):599–600.
22. Carroll RG, Martin SJ. Autophagy in multiple myeloma: what makes you stronger can also kill you. Cancer Cell. 2013;23(4):425–6.
23. Sun K, Guo XL, Zhao QD, Jing YY, Kou XR, Xie XQ, et al. Paradoxical role of autophagy in the dysplastic and tumor-forming stages of hepatocarcinoma development in rats. Cell Death Dis. 2013;4, e501.
24. Wei H, Guan JL. Blocking tumor growth by targeting autophagy and SQSTM1 in vivo. Autophagy. 2015;11(5):854–5.
25. Mathew R, Khor S, Hackett SR, Rabinowitz JD, Perlman DH, White E. Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mol Cell. 2014;55(6):916–30.
26. Ferry DR, Smith A, Malkhandi J, Fyfe DW, DeTakats PG, Anderson D, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996;2(4):659–68.
27. Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, et al. Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas. Cancer. 2010;116(7):1776–82.
28. Euhus DM, Hudd C, LaRegina MC, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol. 1986;31(4):229–34.
29. Zhou J, Liang S, Fang L, Chen L, Tang M, Xu Y, et al. Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. Omics. 2009;13(2):93–103.
30. Bischoff SC. Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care. 2008;11(6):733–40.
31. Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14(1):48.
32. Li C, Liu Y, Liu H, Zhang W, Shen C, Cho K, et al. Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells. Cell Physiol Biochem. 2015;35(4):1303–16.
33. Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Hill JA, et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation. 2012;125(25):3170–81.
34. Geng Y, Kohli L, Klocke BJ, Roth KA. Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. Neuro Oncol. 2010;12(5):473–81.
35. Wu G, Li H, Ji Z, Jiang X, Lei Y, Sun M. Inhibition of autophagy by autophagic inhibitors enhances apoptosis induced by bortezomib in non-small cell lung cancer cells. Biotechnol Lett. 2014;36(6):1171–8.
36. Liang X, Tang J, Liang Y, Jin R, Cai X. Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells. Cell Biosci. 2014;4(1):10.
37. Wu Z, Chang PC, Yang JC, Chu CY, Wang LY, Chen NT, et al. Autophagy blockade sensitizes prostate cancer cells towards Src family kinase inhibitors. Genes Cancer. 2010;1(1):40–9.
38. Ge PF, Zhang JZ, Wang XF, Meng FK, Li WC, Luan YX, et al. Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells. Acta Pharmacol Sin. 2009;30(7):1046–52.
39. Macintosh RL, Timpson P, Thorburn J, Anderson KI, Thorburn A, Ryan KM. Inhibition of autophagy impairs tumor cell invasion in an organotypic model. Cell Cycle. 2012;11(10):2022–9.
40. Wirth M, Joachim J, Tooze SA. Autophagosome formation—the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol. 2013;23(5):301–9.
41. Shin JY, Hong SH, Kang B, Minai-Tehrani A, Cho MH. Overexpression of Beclin1 induced autophagy and apoptosis in lungs of K-rasLA1 mice. Lung Cancer. 2013;81(3):362–70.
42. Wirawan E, Lippens S, Vanden BT, Romagnoli A, Fimia GM, Piacentini M, et al. Beclin1: a role in membrane dynamics and beyond. Autophagy. 2012;8(1):6–17.